Gene transfer of costimulatory molecules B7–1 and B7–2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response (original) (raw)

Gene Therapy volume 4, pages 726–735 (1997)Cite this article

Abstract

Gene transfer of the costimulatory molecules of B7–1 and B7–2 induces a potent antitumor immune response in a variety of tumor models. B cell neoplasms including multiple myeloma (MM) often show little or no expression of B7 antigens; they are therefore a potential target for this approach. To increase the expression of human B7 genes in MM cells, both genes and the neomycin phosphotransferase gene were packaged into recombinant adeno-associated virus vectors (rAAV). The resulting recombinant viruses rAAV/B7–1, rAAV/B7–2 and rAAV/Neo were used to transduce the MM cell lines LP-1 and RPMI 8226. This allowed the transduction of up to 80% of LP-1 cells 4 days after infection with purified rAAV particles. The response of human allogeneic T cells to rAAV/B7–1 and rAAV/B7–2 transduced, γ-irradiated LP-1 cells was assessed by [_3_H]thymidine incorporation, by RT-PCR-based detection of immunostimulatory cytokine transcripts and by ELISA quantification of cytokines in the supernatant. Stimulation of T cells with rAAV/B7–1 or rAAV/B7–2 transduced LP-1 cells resulted in an up to 10-fold increase of T cell proliferation when compared with LP-1 cells transduced with rAAV/Neo. Similar results were obtained with RPMI 8226 cells. Both rAAV/B7–1 and rAAV/B7–2 transduced LP-1 cells stimulated the T cell secretion of IL-2 and IFN-γ. Furthermore, [_51_Cr] release assays showed that rAAV/B7–1 or rAAV/B7–2 transduced LP-1 cells induced a cytolytic T cell (CTL) response, in contrast to LP-1 cells transduced with rAAV/Neo. In all assays, the effects of rAAV/B7–1 and rAAV/B7–2 were similar. Taken together, the results show that rAAV-mediated transfer of B7 genes into MM cell lines is able to enhance the antitumor T cell response and to elicit a cytolytic T cell response.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 6 print issues and online access

$259.00 per year

only $43.17 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Medizinische Klinik, Klinikum Innenstadt, Germany
    C-M Wendtner, A Nolte, R Buhmann, B Emmerich & M Hallek
  2. Laboratory of Molecular Biology, Genzentrum, Ludwig-Maximilians-Universität, Germany
    C-M Wendtner, A Nolte, E Mangold, R Buhmann, E-L Winnacker & M Hallek
  3. MediGene GmbH, Martinsried, Germany
    G Maass
  4. Molecular Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA
    JA Chiorini & RM Kotin

Authors

  1. C-M Wendtner
    You can also search for this author inPubMed Google Scholar
  2. A Nolte
    You can also search for this author inPubMed Google Scholar
  3. E Mangold
    You can also search for this author inPubMed Google Scholar
  4. R Buhmann
    You can also search for this author inPubMed Google Scholar
  5. G Maass
    You can also search for this author inPubMed Google Scholar
  6. JA Chiorini
    You can also search for this author inPubMed Google Scholar
  7. E-L Winnacker
    You can also search for this author inPubMed Google Scholar
  8. B Emmerich
    You can also search for this author inPubMed Google Scholar
  9. RM Kotin
    You can also search for this author inPubMed Google Scholar
  10. M Hallek
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Wendtner, CM., Nolte, A., Mangold, E. et al. Gene transfer of costimulatory molecules B7–1 and B7–2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.Gene Ther 4, 726–735 (1997). https://doi.org/10.1038/sj.gt.3300447

Download citation

Keywords

This article is cited by